Nausea and Vomiting Clinical Trial
Official title:
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
This study will compare the effect of prochlorperazine and ondansetron for the treatment of nausea and vomiting in the emergency department.
Nausea and vomiting can be common symptoms in the emergency department (ED). Antiemetics,
agents to treat nausea and vomiting, include phenothiazine derivatives, prokinetic agents,
and 5-HT3 antagonists. There have been limited studies on the use of these agents in the ED,
and no direct comparisons to 5-HT3 antagonists have been published to date.
Inclusion Criteria:
Patients presenting to the ED with at least one of the following
- nausea
- vomiting documented in the ED
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05016180 -
Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery
|
Phase 2 | |
| Withdrawn |
NCT00891761 -
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
|
Phase 3 | |
| Terminated |
NCT00903396 -
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
|
Phase 2 | |
| Completed |
NCT05533281 -
Efficacy of Three Antiemetics in Preventing Nausea and Vomiting
|
Phase 4 | |
| Recruiting |
NCT01696734 -
Domperidone in Treating Patients With Gastrointestinal Disorders
|
Phase 3 | |
| Completed |
NCT00293384 -
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
|
N/A | |
| Completed |
NCT00006348 -
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
|
Phase 3 | |
| Completed |
NCT00003817 -
Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
|
Phase 2 | |
| Completed |
NCT00004895 -
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
|
Phase 2 | |
| Active, not recruiting |
NCT06045364 -
Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation
|
Phase 1/Phase 2 | |
| Completed |
NCT00978185 -
Acupressure Wristbands or Standard Care in Controlling Nausea Caused by Chemotherapy
|
Phase 3 | |
| Completed |
NCT00064272 -
UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
|
Phase 2 | |
| Completed |
NCT00003213 -
Drugs to Reduce the Side Effects of Chemotherapy
|
Phase 3 | |
| Recruiting |
NCT05690802 -
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
|
N/A | |
| Recruiting |
NCT06314906 -
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
|
Phase 3 | |
| Completed |
NCT03185156 -
The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate
|
Phase 4 | |
| Not yet recruiting |
NCT06382012 -
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
|
Phase 2/Phase 3 | |
| Terminated |
NCT01275664 -
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
|
N/A | |
| Completed |
NCT01590147 -
Supportive Intervention Programs Study
|
N/A | |
| Completed |
NCT00381862 -
Phase II Trial Evaluating the Efficacy and Tolerability of Aprepitant & Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting
|
Phase 2 |